Gamma probe devices market deals with medical devices utilized during surgery to locate cancerous tissues by identifying gamma radiation emitted from radio labelled tracers, injected into the physical health. The market is projected to grow from USD 115.2 Million in 2025 to USD 304.4 million by 2035, thus during the complete period of anticipation, a CAGR of 10.2% is expected.
Surgeons use these devices to provide the rightness on operations as in lymph node dissections, surgeries of breast cancer, and treatment of prostate cancer. The demand for Gamma Probe Devices is expected to extend as the healthcare systems shift towards more personalized and targeted treatments. The progress of technology along with the increasing incidence of cancers worldwide is a vital factor progressing the market advancement.
Market Metrics
| Metric | Value |
|---|---|
| Market Size (2025E) | USD 115.2 Million |
| Market Value (2035F) | USD 304.4 Million |
| CAGR (2025 to 2035) | 10.2% |
As the adoption of minimally invasive surgical procedures grows along with advancements in nuclear medicine and the growing need for precision in cancer diagnostics and treatment, the Gamma Probe Devices Market is anticipated to witness a significant hike in revenue generation from 2025 to 2035. These devices detect radiotracers during surgical procedures, improving the precision of identifying targeted tissues such as the sentinel lymph nodes and thyroid uptake sites.
Hand Held Device to Lead the Market
| Modality | Market Share |
|---|---|
| Hand Held Device | 52.1% |
In 2025, Hand Held Device category is expected to take over 52.1% of the total market. Hand-held devices are some most commonly used not only because of their portability and ease of use but also because they provide real-time imaging and detection during operations.
The benefits of mobility and ergonomic design along with prompt diagnosis are very useful in assisting surgeons during procedures including sentinel lymph node biopsy and thyroid surgeries. All these present attributes are sufficient to drive the increase of hand-held gamma probes.
Sentinel Lymph Node Uptake to Hold the Largest Share
| Application | Market Share |
|---|---|
| Sentinel Lymph Node Uptake | 64.3% |
Sentinel lymph node uptake applications are expected to hold the largest share of 64.3%. This approach is used widely in oncology for staging and spread of cancer, particularly most commonly in sentinel node mapping in breast cancer and melanoma surgeries, wherein exact mapping of lymph node is crucial for accurate diagnosis and treatment.
This large market share of sentinel lymph node uptake in the application segment continues due to its important role in cancer staging and treatment. With increasing attention to cancer surgery, especially focusing on early metastasis detection, accelerated the growth of demand for gamma probe devices.
High Cost of Devices and Lack of Awareness
High cost is the challenge that prevails in the gamma probe devices market. This will limit the device accessibility in some of the developing regions. Small and medium-sized hospitals are more likely to not adopt these advanced technologies because they won't have the budget to spend on such devices. Many surgeons and medical practitioners in some regions also lack awareness of the benefits brought by gamma probe devices, and this will limit their entry into the market as well.
Technological Advancements and Increasing Cancer Screening
Inventions in technology offer substantial chances for growth, with development of portable and compact gamma probe devices being one example. Trends like rise in minimally invasive surgeries and precision medicine, which offers treatments based on individual specifications, will therefore push more demand for these devices. Also, increased investment by the governmental and private sectors in the technologies for screening cancer and diagnosing its causes especially in emerging markets offer huge chances for the growth of the market.
In the USA, the market for gamma probe devices is on the rise, attributed to advances in healthcare technology and mounting surgical applications wherein eyeing lymph nodes is notable, especially for cancer treatment. Gamma probes have accurately established a critical role in sentinel lymph node tissue sample, which is a critical cancer staging procedure, significantly as regards breast and melanoma cancers. The USA market is changing regarding the too soon detection of cancers through promoting health policies and technical innovations. Increased attention among patients about treatment options, mixed with the increased acknowledgment of minimally invasive procedures, is flawlessly impacting the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 10.2% |
In the course of steady growth in the UK, the gamma probe devices marketis finding impetus in recent advances made in the fields of oncology and radiology. These advances are complemented with greater research-and-development activities in the healthcare field and improvements in surgical methods employing gamma probes for the precise detection of cancerous lymph nodes. Greatly facilitating the speed of gamma probe adoption are the improvements in the healthcare system of the UK, which is directed towards promoting patient outcomes through such things as early detection.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 9.8% |
The gamma probe devices market within the European Union is also growing due to the rising number of surgical procedures of patients suffering from cancer and the adoption of advanced technologies for cancer diagnostics. Since the European Union keeps promoting health reforms and cancer care, the rising need for an effective and reliable device to detect sentinel lymph nodes can be assumed. Germany, France, and Italy are experiencing an increase in gamma probe-adopting health care infrastructures.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union | 10.0% |
The penetrating growth exhibited by the gamma probe devices marketin Japan has found its firm footing on account of the ever-strong health care sector and commitment to the advanced technologies for the treatment of cancer. Japan is at the forefront of promoting newer technologies in the medical arena, and with its aging population and rising incidence of cancers, the market for gamma probe devices is profusely growing. Hospitals and medical centers are investing in these devices for the better accuracy and success rates of cancer surgeries.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 9.5% |
In South Korea, the gamma probe devices marketis expected to grow tremendously due to the improvement in technologies for cancer diagnostics and treatment. The healthcare sector of South Korea has its major focus in early detection and precision medicine, thus dramatically increasing the number of gamma probes for accurate lymph node detection in surgeries. Also, as the number of breast cancer and other cancer-related surgeries continues to increase in the country, the demand for these devices is surging.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 10.1% |
The gamma probe devices market is expected to grow rapidly from 2025 to 2035 due to advancements in medical imaging and increasing adoption of minimally invasive procedures across various cancer treatments. Gamma probe devices are important nuclear medicine instruments which mainly guide procedures that are usually part of cancer management such as sentinel lymph node biopsies. Making them appropriate in real-time monitoring for location and ultimate excision of the malignant tissue.
There is a rise in the prevalence of cancers such as melanoma, breast cancer, and prostate cancer, as also the increasing emphasis on early detection and minimally invasive surgeries. These are the major market propellers. Developments in gamma probe technologies, like higher sensitivity, advancement in imaging capability, and improved portability, will further help in the growth of the market.
The overall market size for gamma probe devices market was USD 115.2 million in 2025.
The market is expected to reach USD 304.4 million in 2035.
The demand will be driven by increasing adoption of minimally invasive surgeries, growing prevalence of cancer, technological advancements in diagnostic tools, and the increasing use of gamma probe devices for intraoperative lymph node detection.
The top 5 contributing countries are the United States, Japan, Germany, the United Kingdom, and France.
The handheld gamma probes segment is expected to lead the market due to their portability, ease of use, and effectiveness during surgical procedures.
Explore Similar Insights
Gamma Probe Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
